Rapamycin functionalized carbon Dots: Target-oriented synthesis and suppression of vascular cell senescence

Jiaxin Dong1, Qi Wang2, Tingting Gu1

  • 1Institute for Advanced Ceramics, State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin 150001, PR China.

Insights

This study developed Rapamycin-functionalized carbon dots (Rapa-CDs) to combat vascular cell senescence and cardiovascular diseases. Rapa-CDs enhance Rapamycin

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cardiovascular Research
  • Cellular Senescence

Background:

  • Vascular cell senescence contributes to cardiovascular diseases like hypertension and atherosclerosis.
  • Oxidative stress from reactive oxygen species (ROS) induces cellular senescence.
  • Rapamycin (Rapa) suppresses senescence via the mTOR pathway but suffers from poor solubility and lack of ROS scavenging.

Purpose of the Study:

  • To enhance Rapamycin's solubility and introduce ROS scavenging capabilities.
  • To develop Rapamycin-functionalized carbon dots (Rapa-CDs) for improved anti-senescence properties.
  • To investigate the anti-senescence mechanisms of Rapa-CDs in endothelial cells.

Main Methods:

  • Synthesized Rapa-CDs using free radical polymerization and hydrothermal carbonization.
  • Quantified Rapa-CDs solubility and ROS scavenging efficacy (IC50 for hydroxyl and DPPH radicals).
  • Assessed anti-oxidative stress effects in Human Umbilical Vein Endothelial Cells (HEVECs) by measuring ROS levels.
  • Evaluated Rapa-CDs' impact on senescence markers (mTOR, P53, P21, P16) in Human Umbilical Vein Endothelial Cells (HUVECs).

Main Results:

  • Rapa-CDs exhibited a 3.6 × 10^4 times increase in solubility compared to Rapamycin.
  • Rapa-CDs demonstrated significant ROS scavenging abilities with low IC50 values for hydroxyl and DPPH radicals.
  • Rapa-CDs reduced ROS levels in HEVECs by 87% and alleviated HUVEC senescence by suppressing mTOR overactivation.
  • Rapa-CDs attenuated the expression of senescence-associated proteins P53, P21, and P16.

Conclusions:

  • Target-oriented synthesis of drug-functionalized carbon dots (CDs) is feasible for anti-senescence applications.
  • Rapa-CDs offer improved solubility and ROS scavenging, overcoming limitations of free Rapamycin.
  • Rapa-CDs exert anti-senescence effects through dual pathways: anti-oxidative stress and mTOR inhibition.